80 related articles for article (PubMed ID: 2030632)
1. Stereotactic radiosurgery for squamous cell carcinoma of the nasopharynx.
Kondziolka D; Lunsford LD
Laryngoscope; 1991 May; 101(5):519-22. PubMed ID: 2030632
[TBL] [Abstract][Full Text] [Related]
2. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma.
Pai PC; Chuang CC; Wei KC; Tsang NM; Tseng CK; Chang CN
Head Neck; 2002 Aug; 24(8):748-53. PubMed ID: 12203799
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for loco-regional control and outcome of re-irradiation for patients with poorly-differentiated squamous cell carcinoma of the nasopharynx.
Mitsuhashi N; Sakurai H; Takahashi M; Maebayashi K; Tamaki Y; Hashida I; Akimoto T; Nakamoto S; Takahashi T; Hayakawa K
Jpn J Clin Oncol; 1995 Jun; 25(3):72-8. PubMed ID: 7596051
[TBL] [Abstract][Full Text] [Related]
5. [Irradiation field design according to locoregional relapse sites after radiotherapy of nasopharyngeal carcinoma].
Luo W; Tang YQ; Huang Y; Lu LX; Lu TX
Ai Zheng; 2006 Feb; 25(2):209-11. PubMed ID: 16480588
[TBL] [Abstract][Full Text] [Related]
6. Radiosurgery for skull base malignancies and nasopharyngeal carcinoma.
Cmelak AJ; Cox RS; Adler JR; Fee WE; Goffinet DR
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):997-1003. PubMed ID: 9169805
[TBL] [Abstract][Full Text] [Related]
7. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
8. [The pathological changes of nasopharyngeal carcinoma cases treated by stereotactic radiosurgery].
Hu ZQ; Dong RH; Zhou ZW; Dai JZ; Pan L; Wang BJ
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Nov; 14(11):491-3. PubMed ID: 12563938
[TBL] [Abstract][Full Text] [Related]
9. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
10. [Intensity modulated radiation therapy for 49 patients with recurrent nasopharyngeal carcinoma].
Lu TX; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Zeng ZF; Huang SM; Lin CG; Cui NJ
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):386-9. PubMed ID: 12921573
[TBL] [Abstract][Full Text] [Related]
11. Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma.
Chen HH; Tsai ST; Wang MS; Wu YH; Hsueh WT; Yang MW; Yeh IC; Lin JC
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1408-14. PubMed ID: 17126207
[TBL] [Abstract][Full Text] [Related]
12. Image-guided radiosurgery of head and neck cancers.
Ryu S; Khan M; Yin FF; Concus A; Ajlouni M; Benninger MS; Kim JH
Otolaryngol Head Neck Surg; 2004 Jun; 130(6):690-7. PubMed ID: 15195054
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma.
Low JS; Chua ET; Gao F; Wee JT
Head Neck; 2006 Apr; 28(4):321-9. PubMed ID: 16287135
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
[TBL] [Abstract][Full Text] [Related]
16. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
17. [Lymphoepithelial carcinoma of the nasopharynx: the treatment results following radiotherapy].
Leicher-Düber A; Düber C; Kutzner J; Thelen M
Strahlenther Onkol; 1986 Nov; 162(11):698-703. PubMed ID: 3787454
[TBL] [Abstract][Full Text] [Related]
18. [Impact of dose boost in skull base on recurrence of stage T4 nasopharyngeal carcinoma].
Xie GF; Cao KJ; Li Y; Huang PY
Ai Zheng; 2005 Oct; 24(10):1246-8. PubMed ID: 16219141
[TBL] [Abstract][Full Text] [Related]
19. Radiosurgery for recurrent cranial base cancer arising from the head and neck.
Firlik KS; Kondziolka D; Lunsford LD; Janecka IP; Flickinger JC
Head Neck; 1996; 18(2):160-5; discussion 166. PubMed ID: 8647682
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy of epipharyngeal tumors. 1].
Frommhold H; Gauwerky F
Strahlentherapie; 1972 Nov; 144(5):509-21. PubMed ID: 4646682
[No Abstract] [Full Text] [Related]
[Next] [New Search]
